🇺🇸 FDA
Patent

US 10407409

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

granted A61KA61K31/444A61K31/4545

Quick answer

US patent 10407409 (6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD) held by Takeda Pharmaceutical Company Limited expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/444, A61K31/4545, A61K31/496, A61K31/4985